IRTC Irhythm Holdings, Inc.

$104.41 +2.55%

Healthcare · Surgical & Medical Instruments & Apparatus

Irhythm Holdings, Inc. (IRTC) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $3.4 billion. Shares last traded at $104.41, 50.3% below their 52-week high. Over the past year the stock is down 27.9%. Net profit margin is -6.0%, above the peer median of -7.6%. Revenue grew 26.2% year over year.

Market Cap

$3.4B

Shares Out

32.9M

EPS (TTM)

$-4.38

P/E Ratio

—

P/S Ratio

4.59

P/B Ratio

21.28

Dividend / Share

—

Dividend Yield

—

52-Week High

$209.99

52-Week Low

$101.24

Volume

29,425

Avg Vol (3m)

38,178.73

Performance

-7.33%

-8.25%

-11.37%

-37.73%

YTD

-40.36%

-27.93%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

39.37

SMA (50)

$116.33

SMA (200)

$150.51

Price vs SMA50

-10.25%

Price vs SMA200

-30.63%

ATR (14)

$5.97

Financials

Revenue

$747M

Net Income

$-45M

Gross Margin

70.6%

Operating Margin

-7.7%

Net Margin

-6.0%

Return on Equity

-27.9%

Return on Assets

-4.5%

Current Ratio

5.17

Debt / Equity

0.22

Revenue Growth (YoY)

+26.2%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.43	2026-04-30
FY 2025	$-1.39	2026-02-19
Q3 2025	$-1.57	2025-10-30
Q2 2025	$-1.41	2025-07-31
Q1 2026	$-0.97	2026-04-30
FY 2025	$-3.63	2026-02-19

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

IRTC vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

4.59 / 2.52 med

+82% premium

Net margin vs peers

-6.0% / -7.6% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.